Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repaymentsWages, Salaries and Other
Ratios

SRx Health Solutions (SRXH) Long-Term Debt Repayments (2017 - 2025)

SRx Health Solutions' Long-Term Debt Repayments history spans 7 years, with the latest figure at $7.6 million for Q2 2025.

  • For Q2 2025, Long-Term Debt Repayments rose 443.86% year-over-year to $7.6 million; the TTM value through Jun 2025 reached $9.0 million, down 39.5%, while the annual FY2023 figure was $13.5 million, 147.71% up from the prior year.
  • Long-Term Debt Repayments reached $7.6 million in Q2 2025 per SRXH's latest filing, up from $1.4 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $13.5 million in Q2 2023 to a low of -$2.8 million in Q4 2023.
  • Average Long-Term Debt Repayments over 5 years is $2.8 million, with a median of $1.4 million recorded in 2024.
  • Peak YoY movement for Long-Term Debt Repayments: surged 1566.67% in 2022, then plummeted 720.22% in 2023.
  • A 5-year view of Long-Term Debt Repayments shows it stood at $150000.0 in 2021, then skyrocketed by 200.0% to $450000.0 in 2022, then tumbled by 720.22% to -$2.8 million in 2023, then skyrocketed by 150.16% to $1.4 million in 2024, then soared by 443.86% to $7.6 million in 2025.
  • Per Business Quant, the three most recent readings for SRXH's Long-Term Debt Repayments are $7.6 million (Q2 2025), $1.4 million (Q2 2024), and -$2.8 million (Q4 2023).